Barrett Asset Management’s Novo Nordisk NVO Stock Holding History

Barrett Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$842K	Hold	15,180	–	–	0.04%	120
2021 Q4	$850K	Buy	15,180 +700	+5%	+$37.9K	0.03%	125
2021 Q3	$695K	Hold	14,480	–	–	0.03%	125
2021 Q2	$606K	Hold	14,480	–	–	0.03%	127
2021 Q1	$488K	Buy	14,480 +4,200	+41%	+$150K	0.02%	132
2020 Q4	$359K	Buy	10,280 +330	+3%	+$11.4K	0.02%	141
2020 Q3	$345K	Buy	9,950 +4,200	+73%	+$140K	0.02%	134
2020 Q2	$188K	Buy	+5,750	New	+$183K	0.01%	157
2016 Q2	–	Sell	-466	Closed	-$13K	–	374
2016 Q1	$13K	Buy	+466	New	+$12.5K	﹤0.01%	303

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Barrett Asset Management's NVO Position: Q1 2022 in Review

Barrett Asset Management held its Novo Nordisk (NVO) position steady in Q1 2022 at 15,180 shares worth $842K. The position accounts for 0.04% of the portfolio, ranked #120.

Barrett Asset Management first reported a position in NVO in Q1 2016 and has held it in 9 quarters since. The position peaked at $850K in Q4 2021. 902 funds tracked by Wall St. Rank hold NVO as of Q1 2022.

Barrett Asset Management held 15,180 shares of Novo Nordisk worth $842K as of Q1 2022.
Barrett Asset Management left its Novo Nordisk share count unchanged in Q1 2022.
Novo Nordisk made up 0.04% of Barrett Asset Management's portfolio in Q1 2022, its #120 holding.
Barrett Asset Management first reported a position in Novo Nordisk in Q1 2016 and has held it in 9 quarters since.
Barrett Asset Management's Novo Nordisk position peaked at $850K in Q4 2021.
902 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2022.

Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.